Drug company (FDA labeler)
Mullan Pharmaceutical Inc.
NDC labeler code: 83301
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- GabapentinNeurontin, Gralise, Relgaabi · 5 products
- CelecoxibCelebrex, Vyscoxa, Elyxyb - Celecoxib · 3 products
- Milrinone lactateMilrinone Lactate in Dextrose · 3 products
- Metformin hydrochlorideGlumetza · 3 products
- Vecuronium bromide2 products
- IsofluraneIsoflurane, (Volatile for Inhalation), Terrell, Forane · 2 products
- BumetanideBumex, Enbumyst · 2 products
- AmikacinArikayce · 2 products
- BupropionWellbutrin SR, Aplenzin, Wellbutrin XL · 2 products
- Argatroban2 products
- LabetalolLabetalol HCL in Dextrose · 2 products
- Ganirelix acetateFyremadel · 1 product
- SevofluraneUltane, Sevoflurane, (Volatile for Inhalation), Sojourn · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| November 4, 2025 | ANDA216527 | Isoflurane ISOFLURANE | Shandong |
| April 23, 2025 | ANDA218855 | Ganirelix acetate GANIRELIX ACETATE | Qilu |
| September 19, 2024 | ANDA219116 | Bumetanide BUMETANIDE | Qilu Pharm Hainan |
| March 19, 2024 | ANDA218146 | Amikacin AMIKACIN SULFATE | Qilu |
| August 18, 2023 | ANDA214382 | Sevoflurane SEVOFLURANE | Shandong |
| July 31, 2023 | ANDA217848 | Argatroban ARGATROBAN | Gland |
| January 23, 2023 | ANDA216373 | Milrinone lactate MILRINONE LACTATE | Shandong |
| January 23, 2018 | ANDA210071 | Celecoxib CELECOXIB | Cspc Ouyi |
| October 26, 2017 | ANDA207057 | Gabapentin GABAPENTIN | Cspc Ouyi |
| August 21, 2017 | ANDA208652 | Bupropion BUPROPION HYDROCHLORIDE | Sinotherapeutics Inc |
| July 11, 2016 | ANDA205096 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Cspc Ouyi |
| May 26, 2016 | ANDA205390 | Vecuronium bromide VECURONIUM BROMIDE | Gland |
| April 3, 2012 | ANDA090699 | Labetalol LABETALOL HYDROCHLORIDE | Gland Pharma Ltd |
| March 23, 2005 | ANDA075477 | Gabapentin GABAPENTIN | Cspc Ouyi |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026